Etani, Hayato
Takatori, Sho
Wang, Wenbo
Omi, Jumpei
Amiya, Yusuke
Akahori, Aika
Watanabe, Hirotaka
Sonn, Iki
Okano, Hideyuki
Hara, Norikazu
Hasegawa, Mai
Miyashita, Akinori
Kikuchi, Masataka
Ikeuchi, Takeshi
Morishima, Maho
Saito, Yuko
Murayama, Shigeo
Saito, Takashi
Saido, Takaomi C.
Takai, Toshiyuki
Ohwada, Tomohiko
Aoki, Junken
Tomita, Taisuke
Funding for this research was provided by:
Ministry of Education, Culture, Sports, Science and Technology
Japan Agency for Medical Research and Development
Ono Medical Research Foundation
Ministry of Health, Labour and Welfare
Tokyo Metropolitan Institute for Geriatrics and Gerontology
Moonshot Research and Development Program
Article History
Received: 20 March 2025
Accepted: 14 October 2025
First Online: 20 November 2025
Declarations
:
: This study involving human participants was approved by the Ethics Committees of the Tokyo Metropolitan Institute for Geriatrics and Gerontology (TMIG) (permit number: OF-23), Niigata University (NU) (approval number: G2018-0034), and the University of Tokyo (UT) (approval number: 5–15). Written informed consent was obtained from all participants prior to their inclusion in the study.The iPSC experiments were conducted with the approval of the Ethics Committee at Keio University School of Medicine (approval number: 20080016). Written informed consent was obtained from all donors before sample collection.All animal experiments were performed in accordance with the protocols approved by the Institutional Animal Care and Use Committee at the University of Tokyo (protocol number: P5-04).
: All authors have read and approved the final manuscript for publications. Written informed consent for publication was obtained from all participants prior to data collection.
: H. Okano is a scientific consultant for SanBio, Co. Ltd., and K Pharma Inc. The other authors declare neither financial nor non-financial competing interests.